IP Library Patent Application 11938615
Patent Application
App. No. 11/938,615

Infusion Catheter

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/938,615
Abstract

Devices, methods and systems for delivering drugs and therapeutic fluids to the prostate without requiring piercing of the prostate. An infusion catheter includes at least two inflatable balloons including a distal balloon providing a seal between the bladder and the prostatic urethra as well as a proximal balloon for sealing off the prostatic urethra from the penal urethra. The infusion catheter can include a number of lumens such as, for example, a drug delivery lumen, a drainage lumen, and one or more inflation lumens. The infusion catheter can have one or more drug delivery ports located between the distal balloon and the proximal balloon, wherein each drug delivery port is in fluid communication with the drug delivery lumen. In addition, the catheter can include one or more intermediate balloons at selected locations between the proximal balloon and the distal balloon for isolating portions of the prostate from exposure to treatment.

Claims (29)

1 . An infusion catheter system for delivering a drug or therapeutic fluid during prostate treatment, said infusion catheter system including:

a first inflatable balloon;

a second inflatable balloon, wherein upon inflation said first and second inflatable balloons define a sealed portion of prostatic urethra;

a drug delivery portion, wherein said drug delivery portion is presented intermediate the sealed portion of prostatic urethra,

a drug delivery source operably connected to the drug delivery portion, wherein said drug delivery source provides a drug or therapeutic agent to said drug delivery portion and said drug delivery portion subsequently delivers the drug or therapeutic agent to the sealed portion of the prostatic urethra.

2 . The infusion catheter system of claim 1 further including a third inflatable balloon intermediate said first and second inflatable balloons.

3 . The infusion catheter system of claim 2 wherein the third balloon is non-concentrically located from said first and second inflatable balloons.

4 . The infusion catheter system of claim 2 , wherein the third balloon is concentrically located relative said first and second inflatable balloons.

5 . The infusion catheter system of claim 2 further including a fourth inflatable balloon intermediate said first and second inflatable balloons.

6 . The infusion catheter system of claim 1 further including a drainage lumen, wherein said drainage lumen drains urine that is blocked from exit from the bladder by said first and second inflatable balloons.

7 . The infusion catheter system of claim 1 further including an inflation lumen to inflate the first balloon and the second inflatable balloons.

8 . The infusion catheter system of claim 1 wherein the drug delivery source provides a pressurized drug or therapeutic agent to said drug delivery portion.

9 . The infusion catheter system of claim 1 further including an electroporation system disposed proximate the drug delivery portion.

10 . The infusion catheter system of claim 1 further including an ultrasound system disposed proximate the drug delivery portion.

11 . The infusion catheter system of claim 1 wherein the drug delivery portion includes a plurality of delivery ports that are disposed concentrically about the drug delivery portion.

12 . A method for delivering a drug or therapeutic fluid during prostate treatment, including the steps:

defining and sealing a first end of a prostatic urethra;

defining and sealing a second end of a prostatic urethra;

delivering a drug or therapeutic fluid between the sealed first and second end s through the urethra to the prostate gland.

13 . A method for delivering a drug or therapeutic fluid during prostate treatment as described in claim 12 further including defining and sealing an intermediate portion of said prostatic urethra, between said first and second ends.

14 . A method for delivering a drug or therapeutic fluid during prostate treatment as described in claim 12 further including multiple deliveries of the drug or therapeutic agent.

15 . A method for delivering a drug or therapeutic fluid during prostate treatment as described in claim 12 further wherein the step of delivering a drug or therapeutic fluid comprises delivering a pressurized drug or therapeutic fluid.

16 . A method for delivering a drug or therapeutic fluid during prostate treatment as described in claim 12 further including the step of electroporating the prostatic urethra.

17 . A method for delivering a drug or therapeutic fluid during prostate treatment as described in claim 12 further including the step of applying ultrasound to the prostatic urethra.

18 . An infusion catheter system for delivering a drug or therapeutic fluid to the prostate gland, said infusion catheter comprising:

prostatic urethra sealing means, including first sealing means and second sealing means, wherein said first sealing means for sealing off and defining a first end of a prostatic urethra and wherein said second sealing means for sealing off and defining a second end of a prostatic urethra; and

drug delivery means, wherein said drug delivery means defined between said first end and said second end of said prostatic urethra, wherein said drug delivery means for delivering a drug through the prostatic urethra to the prostate gland.

19 . The infusion catheter system of claim 18 , further comprising a bladder drainage means for draining urine from a patient's bladder that is blocked from exit by said prostatic urethra sealing means.

20 . The infusion catheter system of claim 18 , wherein said drug delivery means includes pressurization means for delivering said drug under pressure.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: AMS RESEARCH, LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 037902/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: AMERICAN MEDICAL SYSTEMS, LLC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 037902/0200 →
RELEASE OF SECURITY INTEREST Recorded Aug 6, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: AMERICAN MEDICAL SYSTEMS, LLC; AMS RESEARCH, LLC; LASERSCOPE
Reel/Frame 036285/0146 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2008
From: HAMEL, KORY P.; CRANK, JUSTIN M.
To: AMS RESEARCH CORPORATION
Reel/Frame 021236/0573 →